Concord Drugs Limited (BOM:538965)
India · Delayed Price · Currency is INR 71.16
-0.37 (-0.52%)
At close: Nov 6, 2026
Concord Drugs Market Cap
Concord Drugs has a market cap or net worth of 937.53 million as of November 6, 2026. It is the 41,325th most valuable company in the world and the 3,390th biggest in India. Its market cap has increased by 32.07% in one year.
Market Cap
937.53M
Enterprise Value
1.08B
Revenue
860.69M
Global Rank
Country Rank
#3,390 India
PE Ratio
41.38
ChartMarket Cap Chart
Since February 23, 2015, Concord Drugs's market cap has increased from 144.80M to 937.53M, an increase of 547.46%. That is a compound annual growth rate of 17.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 937.53M | -13.72% |
| Dec 31, 2025 | 1.09B | 188.24% |
| Dec 31, 2024 | 377.00M | -36.87% |
| Dec 29, 2023 | 597.20M | 109.83% |
| Dec 30, 2022 | 284.61M | 1.24% |
| Dec 31, 2021 | 281.11M | 40.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Speciality Medicines | 1.27B |
| Godavari Drugs | 1.21B |
| Parnax Lab | 1.18B |
| Pharmaids Pharmaceuticals | 1.03B |
| Mercury Laboratories | 957.60M |
| Parmax Pharma | 919.71M |
| Cian Healthcare | 888.00M |
| Amwill Health Care | 832.95M |